The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Thyroid Disorder Market Research Report 2025
Synopsis
Thyroid disorders may lead to elevated or decreased levels of metabolic hormones, leading to medical conditions such as hypothyroidism, hyperthyroidism, etc. falling under the category of thyroid disorders. The global thyroid disorder market is estimated to be driven by the increasing prevalence of thyroid diseases, raising awareness of the disease, and favorable reimbursement and funding policies. According to the Thyroid Disease: Assessment and Management Draft of the National Institute for Health and Care Excellence published in 2017, hypothyroidism was estimated to be prevalent in 27.2% of the total UK population. Such prevalence of thyroid disorders provides suitable backgrounds for the market to grow.
The global Thyroid Disorder market was valued at US$ 2625.9 million in 2023 and is anticipated to reach US$ 3132.5 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.
The incidence of these diseases is on the rise due to various environmental and genetic factors. According to the American Thyroid Association (ATA), more than 12 percent of U.S. citizens may have thyroid disease during their lifetime. People are becoming more aware of the symptoms and causes of these diseases and are taking important steps to improve their health and well-being.
This report aims to provide a comprehensive presentation of the global market for Thyroid Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thyroid Disorder.
Report Scope
The Thyroid Disorder market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thyroid Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thyroid Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer Inc
Allergan
AbbVie Inc.
Merck KGaA
RLC Labs
GlaxoSmithKline Plc
Mylan
Segment by Type
Hypothyroidism
Hyperthyroidism
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Thyroid Disorder companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Thyroid disorders may lead to elevated or decreased levels of metabolic hormones, leading to medical conditions such as hypothyroidism, hyperthyroidism, etc. falling under the category of thyroid disorders. The global thyroid disorder market is estimated to be driven by the increasing prevalence of thyroid diseases, raising awareness of the disease, and favorable reimbursement and funding policies. According to the Thyroid Disease: Assessment and Management Draft of the National Institute for Health and Care Excellence published in 2017, hypothyroidism was estimated to be prevalent in 27.2% of the total UK population. Such prevalence of thyroid disorders provides suitable backgrounds for the market to grow.
The global Thyroid Disorder market was valued at US$ 2625.9 million in 2023 and is anticipated to reach US$ 3132.5 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.
The incidence of these diseases is on the rise due to various environmental and genetic factors. According to the American Thyroid Association (ATA), more than 12 percent of U.S. citizens may have thyroid disease during their lifetime. People are becoming more aware of the symptoms and causes of these diseases and are taking important steps to improve their health and well-being.
This report aims to provide a comprehensive presentation of the global market for Thyroid Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thyroid Disorder.
Report Scope
The Thyroid Disorder market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thyroid Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thyroid Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer Inc
Allergan
AbbVie Inc.
Merck KGaA
RLC Labs
GlaxoSmithKline Plc
Mylan
Segment by Type
Hypothyroidism
Hyperthyroidism
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Thyroid Disorder companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Thyroid Disorder Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hypothyroidism
1.2.3 Hyperthyroidism
1.3 Market by Application
1.3.1 Global Thyroid Disorder Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Thyroid Disorder Market Perspective (2019-2030)
2.2 Thyroid Disorder Growth Trends by Region
2.2.1 Global Thyroid Disorder Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Thyroid Disorder Historic Market Size by Region (2019-2024)
2.2.3 Thyroid Disorder Forecasted Market Size by Region (2025-2030)
2.3 Thyroid Disorder Market Dynamics
2.3.1 Thyroid Disorder Industry Trends
2.3.2 Thyroid Disorder Market Drivers
2.3.3 Thyroid Disorder Market Challenges
2.3.4 Thyroid Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Thyroid Disorder Players by Revenue
3.1.1 Global Top Thyroid Disorder Players by Revenue (2019-2024)
3.1.2 Global Thyroid Disorder Revenue Market Share by Players (2019-2024)
3.2 Global Thyroid Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Thyroid Disorder Revenue
3.4 Global Thyroid Disorder Market Concentration Ratio
3.4.1 Global Thyroid Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Thyroid Disorder Revenue in 2023
3.5 Thyroid Disorder Key Players Head office and Area Served
3.6 Key Players Thyroid Disorder Product Solution and Service
3.7 Date of Enter into Thyroid Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Thyroid Disorder Breakdown Data by Type
4.1 Global Thyroid Disorder Historic Market Size by Type (2019-2024)
4.2 Global Thyroid Disorder Forecasted Market Size by Type (2025-2030)
5 Thyroid Disorder Breakdown Data by Application
5.1 Global Thyroid Disorder Historic Market Size by Application (2019-2024)
5.2 Global Thyroid Disorder Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Thyroid Disorder Market Size (2019-2030)
6.2 North America Thyroid Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Thyroid Disorder Market Size by Country (2019-2024)
6.4 North America Thyroid Disorder Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Thyroid Disorder Market Size (2019-2030)
7.2 Europe Thyroid Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Thyroid Disorder Market Size by Country (2019-2024)
7.4 Europe Thyroid Disorder Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Thyroid Disorder Market Size (2019-2030)
8.2 Asia-Pacific Thyroid Disorder Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Thyroid Disorder Market Size by Region (2019-2024)
8.4 Asia-Pacific Thyroid Disorder Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Thyroid Disorder Market Size (2019-2030)
9.2 Latin America Thyroid Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Thyroid Disorder Market Size by Country (2019-2024)
9.4 Latin America Thyroid Disorder Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Thyroid Disorder Market Size (2019-2030)
10.2 Middle East & Africa Thyroid Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Thyroid Disorder Market Size by Country (2019-2024)
10.4 Middle East & Africa Thyroid Disorder Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Company Detail
11.1.2 Pfizer Inc Business Overview
11.1.3 Pfizer Inc Thyroid Disorder Introduction
11.1.4 Pfizer Inc Revenue in Thyroid Disorder Business (2019-2024)
11.1.5 Pfizer Inc Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Thyroid Disorder Introduction
11.2.4 Allergan Revenue in Thyroid Disorder Business (2019-2024)
11.2.5 Allergan Recent Development
11.3 AbbVie Inc.
11.3.1 AbbVie Inc. Company Detail
11.3.2 AbbVie Inc. Business Overview
11.3.3 AbbVie Inc. Thyroid Disorder Introduction
11.3.4 AbbVie Inc. Revenue in Thyroid Disorder Business (2019-2024)
11.3.5 AbbVie Inc. Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Detail
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Thyroid Disorder Introduction
11.4.4 Merck KGaA Revenue in Thyroid Disorder Business (2019-2024)
11.4.5 Merck KGaA Recent Development
11.5 RLC Labs
11.5.1 RLC Labs Company Detail
11.5.2 RLC Labs Business Overview
11.5.3 RLC Labs Thyroid Disorder Introduction
11.5.4 RLC Labs Revenue in Thyroid Disorder Business (2019-2024)
11.5.5 RLC Labs Recent Development
11.6 GlaxoSmithKline Plc
11.6.1 GlaxoSmithKline Plc Company Detail
11.6.2 GlaxoSmithKline Plc Business Overview
11.6.3 GlaxoSmithKline Plc Thyroid Disorder Introduction
11.6.4 GlaxoSmithKline Plc Revenue in Thyroid Disorder Business (2019-2024)
11.6.5 GlaxoSmithKline Plc Recent Development
11.7 Mylan
11.7.1 Mylan Company Detail
11.7.2 Mylan Business Overview
11.7.3 Mylan Thyroid Disorder Introduction
11.7.4 Mylan Revenue in Thyroid Disorder Business (2019-2024)
11.7.5 Mylan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
